Lipid News

Proteins and lipids —
a complicated relationship?

Eva Sevcsik Gerhard J. Schütz
By Eva Sevcsik and Gerhard J. Schütz
January 01, 2017

Researchers have been discussing for many years the role of the lipid matrix in regulating the activity and the organization of membrane proteins. A variety of effects have been singled out and studied qualitatively and quantitatively in model systems. However, the applicability of those results to living cells is — in many cases — unsatisfactory. Here, we would like to make the point that the complexity of the lipid–protein matrix in cells alters the physico-chemical mechanisms of protein–lipid interactions to an unknown extent when compared to model systems.

In a complex environment, hydrophobic mismatch may cause a protein to fluctuate between different states: (from left to right) hydrophobic mismatch, protein aggregation, protein tilting and recruitment of long-chain lipids.SCHEMATIC PROVIDED BY EVA SEVCSIK AND GERHARD J . SCHÜTZ

We shall discriminate between global and local mechanisms. Global mechanisms are mediated by lipid-bilayer properties; local mechanisms denote a direct molecular interaction between a protein and a lipid molecule. Examples of global effects include curvature, hydrophobic mismatch and preferential partitioning in phase-separated membranes (“rafts”) (1–3); examples of local mechanisms are the direct binding of cholesterol to CRAC domains (4) or of phosphatidylinositol 4,5-bisphosphate to protein subunits (5).

Formally, we may characterize a protein via its chemical potential µ, with the values for two different functional or structural states, µ1 and µ2. If (R is the gas constant, T the temperature), a pronounced preference for one of the two states will occur. In contrast, for , we expect no preferred state.

Most of the data for global mechanisms come from studies on simple, well-defined model systems, which allow for specifically addressing individual parameters. To emphasize the effects, such model systems usually are selected to achieve substantial contrast between µ1 and µ2. Examples would be the partitioning of proteins into ordered versus disordered phases in phase-separated lipid bilayers (6) or the recruitment of proteins to lipid vesicles with different curvature (7). Also, for local mechanisms, chemical potentials are the appropriate means of quantitating a protein’s state: µ1 denotes the lipid-bound state, µ2 the unbound state, and the equilibrium binding constant.

In cell membranes, however, a plethora of lipid species with varying properties, such as different head groups, acyl chain lengths and degrees of saturation, increases the complexity of the situation. The consequence for global mechanisms will be myriad chemical potentials describing the possible states of the protein, which can be approximated by a continuous energy landscape: Proteins essentially fluctuate between the different states. In some cases, cells may amplify the difference in chemical potential by de novo assembly of membrane structures, such as clathrin-coated pits, so that the partitioning or activity contrast will become more pronounced.

Also, in the case of local mechanisms, a variety of lipids may be able to interact with the protein of interest, potentially with only slightly different affinities. This leads to the recruitment of specific lipid species to the vicinity of the protein and an essentially continuous distribution of chemical potentials. Again, in some cases, preferred interactions of the protein with one type of lipid occur, yielding additional discrete values of µ.

What would be the consequences of a continuous distribution of chemical potentials? There would be no clear-cut states of a protein. For example, hydrophobic mismatch, on a stochastic basis, may lead transiently to demixing of the protein, the recruitment of a shell of long-chain lipids and membrane curvature. The system would fluctuate between these scenarios. Only in cases where the energy continuum splits up, or where distinct extra-states exist, can we expect distinct states of a protein. In conclusion, studies of well-defined model systems certainly help our understanding of fundamental physico-chemical properties, but the complexity of the live cell environment provides many more options to minimize the global energy of the system.


References

  1. Milovanovic, D. et al. Nat. Commun.6, 5984 (2015).
  2. McMahon, H.T. & Boucrot, E. J. Cell. Sci.128, 1065 – 1070 (2015).
  3. Van Meer, G. et al. Nat. Rev. Mol. Cell Biol.9, 112 – 124 (2008).
  4. Fantini, J. & Barrantes, F.J., Front. Physiol.4, 31 (2013).
  5. Hamilton, P.J. et al. Nat. Chem. Biol.10, 582 – 589 (2014).
  6. Dietrich, C. et al. Proc. Natl. Acad. Sci. USA98, 10642 – 10647 (2001).
  7. Hatzakis, N.S. et al. Nat. Chem. Biol.5, 835 – 841 (2009).
Eva Sevcsik
Eva Sevcsik

Eva Sevcsik is a researcher at the Institute of Applied Physics at TU Wien in Austria.

Gerhard J. Schütz
Gerhard J. Schütz

Gerhard J. Schütz leads the biophysics group at the Institute of Applied Physics at TU Wien.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Branon works to break barriers in science and higher education
ASBMB Annual Meeting

Branon works to break barriers in science and higher education

March 03, 2021

Tess Branon will speak during the Molecular & Cellular Proteomics early career researcher session on proximity-dependent biotinylation at the 2021 ASBMB Annual Meeting.

Brain Injury Awareness Month 2021
Health Observance

Brain Injury Awareness Month 2021

March 01, 2021

In the U.S., about 2.8 million people sustain a traumatic brain injury annually. Learn about recent research on TBI-related dementia, dysfunctional mitochondria and other work powering the march toward better therapies.

The evolution of proteins from mysteries to medicines
Essay

The evolution of proteins from mysteries to medicines

February 27, 2021

An essay in observance of National Protein Day.

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Progeria: From the unknown to the first FDA-approved treatment
Health Observance

Progeria: From the unknown to the first FDA-approved treatment

February 25, 2021

Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.